Pharma news
Americas
David Manspeizer and Greg Chopskie have joined Morrison & Foerster’s intellectual property litigation practice group in its New York and Washington offices respectively. 18 October 2016
Africa
With specialist IP providers offering post-M&A services at lower cost than traditional law firms, have clients been overspending in the past? Melissa Pillote on behalf of Dennemeyer reports. 18 October 2016
Pharma
The Court of Justice of the European Union has ruled that certain legislation on supplementary protection certificates applies to SPCs granted by a country before it has joined the EU. 17 October 2016
Americas
The US Court of Appeals for the Federal Circuit has affirmed a district court’s patent ruling in favour of global pharma company Endo and Scotland-based Strakan International in a case against Actavis. 17 October 2016
Americas
Amgen has filed a complaint against Apotex for allegedly infringing a patent centring on Sensipar tablets. 14 October 2016
Americas
The Massachusetts Institute of Technology has succeeded in a patent infringement case against Shire Pharmaceuticals. 14 October 2016
Pharma
The EU General Court’s decision in September to fine Lundbeck nearly €150 million over several pay-for-delay deals will encourage the European Commission to take further action against similar agreements, say Bernd Allekotte and Franz Zimmer of Grünecker. 14 October 2016
Pharma
Pfizer has lost a battle against Actavis in a second medical use patent case centring on the drug Lyrica. 13 October 2016
Pharma
The English High Court has ruled on a competition case between NHS England and Servier, holding that Servier should be granted permission to re-amend its defence. 13 October 2016
Pharma
The UK government must ensure that the vital market for orphan drugs will continue to prosper following Brexit, says Kei Enomoto of Maucher Jenkins. 13 October 2016